Malachite Innovations Retains Investment Banking Firm to Assist in Implementation of Strategic Plan for Cannabinoid Drug Development Business
Company will focus on core impact investing strategy in Appalachia CLEVELAND,...
read more
MALACHITE INNOVATIONS REPORTS THIRD QUARTER 2023 RESULTS
CLEVELAND, OHIO – (November 14, 2023) – MALACHITE INNOVATIONS, INC. (OTC...
read more
MALACHITE INNOVATIONS ANNOUNCES CLOSING OF $1.0 MILLION CAPITAL RAISE TO FUND FIRST ACQUISITION OF FORMER MINE LAND
CLEVELAND, OHIO – (September 15, 2023) – MALACHITE INNOVATIONS, INC. (OTC...
read more
MALACHITE INNOVATIONS ANNOUNCES CLOSING THE ACQUISITION OF ITS THIRD RECLAMATION BUSINESS IN WEST VIRGINIA
CLEVELAND, OHIO – (September 5, 2023) – MALACHITE INNOVATIONS, INC. (OTC...
read more
MALACHITE INNOVATIONS REPORTS SECOND QUARTER 2023 RESULTS
CLEVELAND, OHIO – (August 1, 2023) – MALACHITE INNOVATIONS, INC. (OTC Mkts:...
read more
MALACHITE INNOVATIONS AND ITS SUBSIDIARY GRAPHIUM BIOSCIENCES RELEASE NEW INVESTOR PRESENTATIONS AND ANNOUNCE UPCOMING FUNDRAISING EFFORTS
CLEVELAND, OHIO – (June 1, 2023) – MALACHITE INNOVATIONS, INC. (OTC Mkts:...
read more
MALACHITE INNOVATIONS ANNOUNCES CONTINUED EXPANSION OF ITS SENIOR LEADERSHIP TEAM WITH THREE NEW ADDITIONS
CLEVELAND, OHIO – (June 1, 2023) – MALACHITE INNOVATIONS, INC. (OTC Mkts:...
read more
MALACHITE INNOVATIONS REPORTS FIRST QUARTER 2023 RESULTS
CLEVELAND, OHIO – (May 31, 2023) – MALACHITE INNOVATIONS, INC. (OTC Mkts:...
read more
MALACHITE INNOVATIONS ANNOUNCES ENGAGEMENT WITH SUNDAY CREEK HORIZONS, AN APPALACHIAN-FOCUSED CONSULTING FIRM
CLEVELAND, OHIO – (May 16, 2023) – MALACHITE INNOVATIONS, INC. (OTC Mkts:...
read more
MALACHITE INNOVATIONS ANNOUNCES CAPITAL RAISE LED BY BERNIE KOSAR, EDWARD FEIGHAN AND TWO OUTSIDE PRIVATE INVESTMENT FIRMS
CLEVELAND, OHIO – (April 13, 2023) – MALACHITE INNOVATIONS, INC. (OTC Mkts:...
read more
2022 ANNUAL REPORT HIGHLIGHTS
CLEVELAND, OHIO – (April 5, 2023) – MALACHITE INNOVATIONS, INC. (OTC Mkts:...
read more
MALACHITE INNOVATIONS ANNOUNCES FORMER NFL QUARTERBACK BERNIE KOSAR HAS JOINED THE COMPANY AS A STRATEGIC ADVISOR
CLEVELAND, OHIO – (December 21, 2022) – MALACHITE INNOVATIONS, INC. (OTC...
read more
MALACHITE INNOVATIONS LAUNCHES NEW BUSINESS FOCUSED ON MITIGATION BANKING TO RESTORE ENVIRONMENTALLY DEGRADED STREAMS AND WETLANDS
CLEVELAND, OHIO – (December 20, 2022) – MALACHITE INNOVATIONS, INC. (OTC...
read more
MALACHITE INNOVATIONS LAUNCHES TERRA PRETA, A NEW BUSINESS FOCUSED ON PRODUCING BIOCHAR FOR AGRICULTURAL AND WATER FILTRATION MARKETS
CLEVELAND, OHIO – (December 15, 2022) – MALACHITE INNOVATIONS, INC. (OTC...
read more
MALACHITE INNOVATIONS ANNOUNCES EXPANSION OF SENIOR LEADERSHIP TEAM AND ENGAGEMENT OF TWO NEW STRATEGIC ADVISORS
CLEVELAND, OHIO – (December 1, 2022) – MALACHITE INNOVATIONS, INC. (OTC...
read more
MALACHITE INNOVATIONS LAUNCHES NEW BUSINESS FOCUSED ON PROVIDING ECO-FRIENDLY, TECHNOLOGY-DRIVEN SECURITY SERVICES TO ACTIVE AND FORMER MINE SITES USING MILITARY VETERANS AND FIRST RESPONDERS
CLEVELAND, OHIO – (November 29, 2022) – MALACHITE INNOVATIONS, INC. (OTC...
read more
MALACHITE INNOVATIONS ANNOUNCES CLOSING OF $3.0 MILLION CAPITAL RAISE AND INITIAL ESG ACQUISITIONS
CLEVELAND, OHIO – (May 13, 2022) – MALACHITE INNOVATIONS, INC. (OTC Mkts:...
read more
MALACHITE INNOVATIONS ANNOUNCES SIGNED LETTER OF INTENT WITH RANGE
ENVIRONMENTAL RESOURCES, INC.
CLEVELAND, OHIO – (March 15, 2022) – MALACHITE INNOVATIONS, INC. (OTC Mkts:...
read more
MALACHITE INNOVATIONS ANNOUNCES TWO GRANTED U.S. PATENTS AND NEW PCT PATENT FILING
CLEVELAND, OHIO – (December 28, 2021) – MALACHITE INNOVATIONS, INC. (OTC...
read more
VITALITY BIOPHARMA ADOPTS NEW NAME – MALACHITE INNOVATIONS, INC.
New Corporate Name Reflects Company’s Expanded Business Strategy, Corporate...
read more
VITALITY BIOPHARMA ANNOUNCES EFFECTIVE S-1 REGISTRATION STATEMENT AND DTC ELIGIBILITY
CLEVELAND, OHIO – (September 2, 2021) – Vitality Biopharma, Inc. (OTC Mkts:...
read more
VITALITY BIOPHARMA ENTERS INTO $5 MILLION EQUITY LINE FINANCING RELATIONSHIP WITH INSTITUTIONAL INVESTOR
CLEVELAND, OHIO – (August 20, 2021) – Vitality Biopharma, Inc. (VBIO)...
read more
FDA GRANTS VITALITY BIOPHARMA ORPHAN DRUG DESIGNATION FOR VBX-100 PRODRUG
CLEVELAND, OHIO – (August 10, 2021) – Vitality Biopharma, Inc. (VBIO)...
read more
CEO LETTER TO SHAREHOLDERS
To the Shareholders of Vitality Biopharma, Inc.: In October 2018, Vitality...
read more
VITALITY BIOPHARMA RETAINS DELMORGAN & CO. TO EXPLORE STRATEGIC ALTERNATIVES
CLEVELAND, OHIO – (September 25, 2020) – Vitality Biopharma, Inc. (OTCQB:...
read more
VITALITY BIOPHARMA BOARD UPDATE
CLEVELAND, OHIO – (April 27, 2020) — Vitality Biopharma, Inc. (Ticker:...
read more
VITALITY BIOPHARMA WELCOMES NEW EXECUTIVE MANAGEMENT TEAM
– Appointment of Current Director Michael Cavanaugh as Interim Chief...
read more
VITALITY BIOPHARMA CO-FOUNDER DR. AVTAR DHILLON RESIGNS FROM BOARD OF DIRECTORS
LOS ANGELES, CA – (April 25, 2019) — Vitality Biopharma, Inc. (Ticker:...
read more
VITALITY BIOPHARMA APPOINTS FORMER OHIO GOVERNOR RICHARD F. CELESTE TO BOARD
LOS ANGELES, Jan. 24, 2019 — Vitality Biopharma, Inc. (Ticker: VBIO)...
read more
VITALITY BIOPHARMA ANNOUNCES CORPORATE UPDATES AND COMPLETION OF AN SEC EXAMINATION
Company appoints two new directors including the Hon. Edward Feighan as new...
read more
